I received the following update from the CHOP Hyperinsulinism Center on the diazoxide that many of you have written about with concerns. This is what was shared with me:
“Yesterday a TEVA Quality Assurance Auditor gave the following explanation for the questionable diazoxide batch:
– There is no official recall of this batch, which is why people are being sent bottles from the same lot.
– According to TEVA this lot is up to specifications which state that the appearance of Proglycem can vary from very white, to light brown, to pink.
– Since most people have not ever seen Proglycem quite so white in appearance, they understand the hesitation to use it, however the company is NOT testing the bottles because they do meet the medication specification standards. They will take the bottles back and send more, but there could be issues with availability.
– There is no official shortage, however if someone sends back medication from this “different appearing” lot and that’s the only lot that their distributor has locally available, then they may not be able to get more meds for a while. So basically, the rejection of Proglycem bottles from this lot could cause local shortages in areas where this is the only available lot.”
